Effect of different therapeutic modalities on spontaneous GH secretion in acromegalic patients

Clinical Endocrinology

Volumn 63, Issue 3, 2005, Pages 294-297

  Resmini, Eugenia ^a   Barreca, Antonina ^a   Ferone, Diego ^a   Giusti, Massimo ^a   Sidoti, Marilena ^a   Minuto, Francesco ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CORTICOTROPIN; FOLLITROPIN; GROWTH HORMONE; LUTEINIZING HORMONE; PROTEIN IGFBP 3; SOMATOMEDIN BINDING PROTEIN 1; SOMATOSTATIN DERIVATIVE; THYROTROPIN; UNCLASSIFIED DRUG;

ACROMEGALY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE RELEASE; HUMAN; HYPOPHYSIS FUNCTION; HYPOTHALAMUS LESION; MALE; PRIORITY JOURNAL; PROTEIN SECRETION; RADIOTHERAPY; STATISTICAL ANALYSIS; TRANSSPHENOIDAL SURGERY;

ACROMEGALY; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARRIER PROTEINS; FEMALE; FOLLOW-UP STUDIES; GLYCOPROTEINS; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; OCTREOTIDE; PITUITARY IRRADIATION; STATISTICS, NONPARAMETRIC;

EID: 24144466449     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02340.x     Document Type: Article

References (19)

1. Orme, S.M., McNally, R.J., Cartwright, R.A. & Belchetz, P.E. (1998) Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. Journal of Clinical Endocrinology and Metabolism, 83, 2730-2734.
2. Ayuk, J., Clayton, R.N., Holder, G., Sheppard, M.C., Stewart, P.M. & Bates, A.S. (2004) Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 89, 1613-1617.
3. Barkan, A.L., Halasz, I., Dornfeld, K.J., Jaffe, C.A., Friberg, R.D., Chandler, W.F. & Sandler, H.M. (1997) Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 83, 3187-3191.
4. Peacey, S.R. & Shalet, S.M. (1999) Growth hormone pulsatility in acromegaly following radiotherapy. Pituitary, 2, 63-69.
5. Peacey, S.R., Toogood, A.A., Veldhuis, J.D., Thorner, M.O. & Shalet, S.M. (2001) The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy. Journal of Clinical Endocrinology and Metabolism, 86, 259-266.
6. Giustina, A., Barkan, A., Casanueva, F., Cavagnini, F., Frohman, L., Ho, K., Veldhuis, J., Wass, J., Von Werder, K. & Melmed, S. (2000) Criteria for cure of acromegaly: Consensus Statement. Journal of Clinical Endocrinology and Metabolism, 85, 526-529.
7. Freda, P.U., Post, K.D., Powell, J.S. & Wardlaw, S.L. (1998) Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 83, 3808-3816.
8. Dimaraki, E.W., Jaffe, C.A., DeMott-Friberg, R., Chandler, W.F. & Barkan, C. (2002) Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up. Journal of Clinical Endocrinology and Metabolism, 87, 3537-3542.
9. Minuto, F., Resmini, E., Boschetti, M., Arvigo, M., Sormani, M.P., Giusti, M., Ferone, D. & Barreca, A. (2004) Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system. Clinical Endocrinology, 61, 138-144.
10. Barreca, A., Ciccarelli, E., Minuto, F., Bruzzi, P., Giordano, G. & Camanni, F. (1989) Insulin-like growth factor I and daily growth profile in the assessment of active acromegaly. Acta Endocrinologica, 120, 629-635.
11. Pincus, S.M., Hartman, M.L., Roelfsema, F., Thorner, M.O. & Veldhuis, J.D. (1999) Hormone pulsatility discrimination via coarse and short-time sampling. American Journal of Physiology, 277, 948-957.
12. Farhy, L.S. & Veldhuis, J.D. (2003) Joint pituitary-hypothalamic and intrahypothalamic autofeedback construct of pulsatile growth hormone secretion. American Journal of Physiology, Regulatory, Integrative and Comparative Physiology, 285, 1240-1249.
13. Grottoli, S., Razzore, P., Gaia, D., Gasperi, M., Giusti, M., Colao, A., Ciccarelli, E., Gasco, V., Martino, E., Ghigo, E. & Camanni, F. (2003) Three-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly. Journal of Endocrinological Investigation, 26, 123-127.
14. Giustina, A. & Melmed, S. (2003) Acromegaly consensus: the next steps. Journal of Clinical Endocrinology and Metabolism, 88, 1913-1914.
15. Daughaday, W.H., Mariz, I.K. & Blethen, S.L. (1980) Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. Journal of Clinical Endocrinology and Metabolism, 51, 781-788.
16. Ogilvy-Stuart, A.L., Wallace, W.H. & Shalet, S.M. (1994) Radiation and neuroregulatory control of growth hormone secretion. Clinical Endocrinology, 41, 163-168.
17. Peacey, S.R., Toogood, A.A. & Shalet, S.M. (1998) Hypothalamic dysfunction in 'cured' acromegaly is treatment modality dependent. Journal of Clinical Endocrinology and Metabolism, 83, 1682-1686.
18. Semer, M., Faria, A.C., Nery, M., Salgado, L.R., Knoepfelmacher, M., Wajchenberg, B.L. & Liberman, B. (1995) Growth hormone pulsatility in active and cured acromegalic subjects. Journal of Clinical Endocrinology and Metabolism, 80, 3767-3770.
19. Wass, J.A.H. (2003) Radiotherapy in acromegaly: a protagonist's viewpoint. Clinical Endocrinology, 58, 128-131.